Frequentist rules for regulatory approval of subgroups in phase III trials: A fresh look at an old problem.
Saved in:
| Title: | Frequentist rules for regulatory approval of subgroups in phase III trials: A fresh look at an old problem. |
|---|---|
| Authors: | Edgar K; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Jackson D; Statistical Innovation, Oncology R&D, AstraZeneca, AstraZeneca, Cambridge, UK., Rhodes K; Statistical Innovation, Oncology R&D, AstraZeneca, AstraZeneca, Cambridge, UK., Duffy T; Statistical Innovation, BioPharmaceutical R&D, AstraZeneca, Gothenburg, Sweden., Burman CF; Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK., Sharples LD; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK. |
| Source: | Statistical methods in medical research [Stat Methods Med Res] 2021 Jul; Vol. 30 (7), pp. 1725-1743. Date of Electronic Publication: 2021 Jun 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9212457 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0334 (Electronic) Linking ISSN: 09622802 NLM ISO Abbreviation: Stat Methods Med Res Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0334 |
|---|---|
| DOI: | 10.1177/09622802211017574 |
